Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study
Abstract Background Multidrug-resistant, rifampicin-resistant, and extensively drug-resistant tuberculosis (MDR-TB/RR-TB/XDR-TB) present significant treatment challenges, requiring effective and safe therapeutic regimens. This study aims to assess the efficacy and safety of a 24-week regimen that in...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2025-12-01
|
| Serie: | BMC Infectious Diseases |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12879-025-11945-9 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|